3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
4
Meningeal Carcinomatosis
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Glioma
2
Glioblastoma
2
Astrocytoma
2
Uveal Melanoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Nevus
1
Meningeal Neoplasms
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Monocytic, Acute
1
Leukemia, Hairy Cell
1
Germinoma
1
Diabetes Insipidus
1
Interventions
Cyclophosphamide
17
fludarabine phosphate
12
pembrolizumab
11
Brentuximab Vedotin
11
Nivolumab
10
Mycophenolic Acid
10
fludarabine
9
Doxorubicin
9
Dacarbazine
9
Whole-Body Irradiation
8
Vinblastine
7
Magnetic Resonance Spectroscopy
7
Filgrastim
7
Etoposide
7
Cyclosporine
7
Specimen Handling
6
Sirolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
Tacrolimus
4
Gemcitabine
4
pegfilgrastim
3
Vinorelbine
3
Radiation
3
Cyclosporins
3
Carmustine
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Spinal Puncture
×
90 days
×
Clear all
No trials found.